STLN Buybacks
5 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–5; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Starling Oncology, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| Starling Oncology, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Starling Oncology, Inc. | 2022-12-31 | Reported repurchase cash | $0.00 |
| Starling Oncology, Inc. | 2022-06-30 | Reported repurchase cash | $9M |
| Starling Oncology, Inc. | 2021-12-31 | Reported repurchase cash | $0.00 |